Drug Profile
Interferon alpha-2b biosimilar - Biosidus
Alternative Names: Bioferon; Biosidus interferon alpha 2b; Citopheron™; Ganapar™; Inter 2B™; Zavinex™Latest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Biosidus S.A.
- Class Antineoplastics; Antivirals; Interferons; Recombinant proteins
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Cancer; Hepatitis B; Hepatitis C; Kaposi's sarcoma
Most Recent Events
- 29 Apr 2013 Launched for Cancer in Thailand (Parenteral)
- 29 Apr 2013 Launched for Hepatitis B in Thailand (Parenteral)
- 29 Apr 2013 Launched for Hepatitis C in Thailand (Parenteral)